Alogliptin and Pioglitazone (Perrigo New York Inc)
Welcome to the PulseAid listing for the Alogliptin and Pioglitazone drug offered from Perrigo New York Inc. This Dipeptidyl Peptidase 4 Inhibitors [MoA],Dipeptidyl Peptidase 4 Inhibitor [EPC],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Perrigo New York Inc |
| NON-PROPRIETARY NAME: | Alogliptin Benzoate and Pioglitazone hydrochloride |
| SUBSTANCE NAME: | ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Dipeptidyl Peptidase 4 Inhibitors [MoA],Dipeptidyl Peptidase 4 Inhibitor [EPC],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2016-04-08 |
| END MARKETING DATE: | 0000-00-00 |
Alogliptin and Pioglitazone HUMAN PRESCRIPTION DRUG Details:
| Item Description | Alogliptin and Pioglitazone from Perrigo New York Inc |
| LABELER NAME: | Perrigo New York Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 12.5; 15(mg/1; mg/1) |
| START MARKETING DATE: | 2016-04-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 45802-238_c5d36323-ff86-4dd0-8c4d-1c3d5197d7be |
| PRODUCT NDC: | 45802-238 |
| APPLICATION NUMBER: | NDA022426 |
Other ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
